AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Compare diversification outcomes of common stock index options in retirement planning, highlighting practical considerations.
25,636 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Micron Technology stunned investors with an earnings beat and an ultra-high gross margin, suggesting it is riding an ...
Rumors are swirling about meta platforms reportedly getting into prediction markets. This potential pivot could redef...
A major government-backed funding signal could redefine the trajectory of this explosive quantum stock. This in-depth...
XRP ETFs posted their first weekly red bar after months of inflows, while Bitcoin and Ethereum ETFs logged solid gain...
Tokenized shares backed by real company stock are moving across borders. Learn how kraken parent company makes this p...
Ethereum is shaping a decisive move as the 4-hour chart tightens into a triangle. A breakout above the upper line cou...
Urban Outfitters posted a strong Q4 2026 with record revenue, led by a rebound in its flagship Urban Outfitters brand...
A Worthington Steel board director recently sold 2,500 shares as the company pursues a major acquisition. Learn what ...
Tariffs roiled markets, sending GLD down as real interest rates climbed and inflation stayed sticky. The gold ETF rem...
EverCommerce stock has faced volatility in 2026. With a focus on cash flow, analysts weigh a path to a $12 target, de...
Bitcoin faces a pivotal moment as the Fed meets tonight. The decision tonight will likely determine whether BTC break...